Browsing by Author "Tsianos, E."
Now showing items 1-2 of 2
-
Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)
Zachou, K.; Liaskos, C.; Christodoulou, D.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Gerovasilis, F.; Tsianos, E.; Dalekos, G. (2002) -
Hepatitis C virus survival curve analysis in naïve patients treated with PegInterferon α-2b plus ribavirin. A randomized controlled trial for induction with high doses of PegInterferon and predictability of sustained viral response from early virologic data
Mimidis, K.; Papadopoulos, V. P.; Elefsiniotis, I.; Koliouskas, D.; Ketikoglou, I.; Paraskevas, E.; Kanatakis, S.; Chrysagis, D.; Dalekos, G. N.; Tzathas, C.; Protopapas, A.; Gigi, E.; Tsianos, E.; Kartalis, G. (2006)Aim. To evaluate the significance of induction with high doses of pegylated interferon α-2b (Peg-IFNα-2b) and the predictability of sustained virologic response (SVR) in naïve patients with chronic hepatitis C. Methods. ...